|
⚲
|
| Keyboard |
| Calabrese Jeffrey
✚
|
|
|---|---|
| CIK # | 0001892279 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001892279] | |
| 4 | [0001892279] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Calabrese Jeffrey | |
| Aerie Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aerie Pharmaceuticals Inc AERI
Common Stock
|
2022-11-21 | Disposed to issuer | 18,585 | $15.25 | 283,421 |
|
Aerie Pharmaceuticals Inc AERI
Stock Option (right to buy) · derivative
|
2022-11-21 | Disposed to issuer | 6,257 | $4.23 | 26,467 |
|
Aerie Pharmaceuticals Inc AERI
Stock Option (right to buy) · derivative
|
2022-11-21 | Disposed to issuer | 20,774 | $6.89 | 143,133 |
|
Aerie Pharmaceuticals Inc AERI
Common Stock
|
2022-11-01 | Tax withheld | 179 | $15.22 | 2,724 |
|
Aerie Pharmaceuticals Inc AERI
Common Stock
|
2022-08-14 | Tax withheld | 265 | $11.57 | 3,066 |
|
Aerie Pharmaceuticals Inc AERI
Common Stock
|
2022-07-01 | Grant | 11,276 | $0.00 | |
|
Aerie Pharmaceuticals Inc AERI
Common Stock
|
2022-07-01 | Tax withheld | 266 | $8.36 | 2,224 |
|
Aerie Pharmaceuticals Inc AERI
Stock Option (right to buy) · derivative
|
2022-07-01 | Grant | 20,774 | $0.00 |